Cited by 406Schizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Cognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations

Lewis, David A., Moghaddam, Bita·2006·Archives of Neurology

DOI 10.1001/archneur.63.10.1372

Open this paper in CoChat — free account

Abstract

Impairments in certain cognitive functions mediated by the dorsolateral prefrontal cortex, such as working memory, are core features of schizophrenia. Convergent findings suggest that these disturbances are associated with alterations in markers of inhibitory gamma-aminobutyric acid and excitatory glutamate neurotransmission in the dorsolateral prefrontal cortex. Specifically, reduced gamma-aminobutyric acid synthesis is present in the subpopulation of gamma-aminobutyric acid neurons that express the calcium-binding protein parvalbumin. Despite presynaptic and postsynaptic compensatory responses, the resulting impaired inhibitory regulation of pyramidal neurons contributes to a reduction in the synchronized neuronal activity that is required for working memory function. Several lines of evidence suggest that these changes may be either secondary to or exacerbated by impaired signaling via the N-methyl-d-aspartate class of glutamate receptors. These findings suggest specific targets for therapeutic interventions to improve cognitive function in individuals with schizophrenia.

Integrity signals

Registry

Crossref · 10.1001/archneur.63.10.1372

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Self-citation
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Self-citation
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938
Self-citation
Cognitive Impairment in Schizophrenia Is the Core of the Disorder
Elvevag, B., & Goldberg, T. E. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.10 · Cited by 835 · cited 1×
“Although psychosis is usually the most striking clinical aspect of schizophrenia, disturbances in certain cognitive processes, such as attention, certain types of memory, and executive functions, are considered to be the core features of the illness.(4) Such cognitive disturbances (1) can be present for years before t…”
Background
Catching Up on Schizophrenia
Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 833
Self-citation
Gamma Oscillations Correlate with Working Memory Load in Humans
Howard, M. W. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg084 · Cited by 766
Decreased Glutamic Acid Decarboxylase67 Messenger RNA Expression in a Subset of Prefrontal Cortical γ-Aminobutyric Acid Neurons in Subjects With Schizophrenia
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
Self-citation

Show all 41 references

Sorted by citations

Items 201–300 of 406

Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia
Takahashi, S., Ukai, S., Kose, A., Hashimoto, T., Iwatani, J., Okumura, M., Tsuji, T., & Shinosaki, K. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.033 · Cited by 36
The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys
Cannon, C. E., Puri, V., Vivian, J. A., Egbertson, M. S., Eddins, D. M., & Uslaner, J. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.003 · Cited by 33
Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin
Turner, C. P., DeBenedetto, D., Ware, E., Stowe, R. C., Lee, A. J., Swanson, J. M., Walburg, C., Lambert, A., Lyle, M. A., Desai, P., et al. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-2059-z · Cited by 33
Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia
Pinacho, R., Villalmanzo, N., Meana, J. J., Ferrer, I., Berengueras, A., Haro, J. M., Villén, J., & Ramos, B. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.050 · Cited by 33
Prefrontal GABAB Receptor Activation Attenuates Phencyclidine-Induced Impairments of Prepulse Inhibition: Involvement of Nitric Oxide
Fejgin, K., Pålsson, E., Wass, C., Finnerty, N. J., Lowry, J., & Klamer, D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.225 · Cited by 34
Stimulation of Metabotropic Glutamate (mGlu) 2 Receptor and Blockade of mGlu1 Receptor Improve Social Memory Impairment Elicited by MK-801 in Rats
Hikichi, H., Kaku, A., Karasawa, J.-I., & Chaki, S. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13036fp · Cited by 33
Behavioral Phenotypes for Negative Symptoms in Animal Models of Schizophrenia
Miyamoto, Y., & Nitta, A. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r02cr · Cited by 32
The immunhistochemical examination of GABAergic interneuron markers in the dorsolateral prefrontal cortex of patients with late-life depression
Khundakar, A. A., Morris, C. M., & Thomas, A. J. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210001444 · Cited by 32
Emotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanisms
Anticevic, A., Schleifer, C., & Cho, Y. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/aanticevic · Cited by 34
DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity
Callicott, J. H., Feighery, E. L., Mattay, V. S., White, M. G., Chen, Q., Baranger, D. A. A., Berman, K. F., Lu, B., Song, H., Ming, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67510 · Cited by 31
Sensorimotor gating, working and social memory deficits in mice with reduced expression of the vesicular glutamate transporter VGLUT1
Inta, D., Vogt, M. A., Perreau‐Lenz, S., Schneider, M., Pfeiffer, N., Wojcik, S. M., Spanagel, R., & Gass, P. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.012 · Cited by 31
NMDA Receptors Control Cue-Outcome Selectivity and Plasticity of Orbitofrontal Firing Patterns during Associative Stimulus-Reward Learning
van Wingerden, M., Vinck, M. A., Tijms, V., Ferreira, I. R. S., Jonker, A. J., & Pennartz, C. M. A. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.039 · Cited by 32
Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution
Dienel, S. J., Enwright, J. F., Hoftman, G. D., & Lewis, D. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.003 · Cited by 34
Self-citation
Variation in the purinergic P2RX7 receptor gene and schizophrenia
Hansen, T. F., Jakobsen, K. D., Fenger, M., Nielsen, J., Krane, K., Fink‐Jensen, A., Lublin, H., Ullum, H., Timm, S., Wang, A. G., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.026 · Cited by 31
GABAergic mRNA expression is upregulated in the prefrontal cortex of rats sensitized to methamphetamine
Wearne, T. A., Parker, L. M., Franklin, J. L., Goodchild, A. K., & Cornish, J. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.026 · Cited by 31
NRG1 and Synaptic Function in the CNS
Fischbach, G. D. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.009 · Cited by 31
A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers
Boland, K., Moschetti, V., Dansirikul, C., Pichereau, S., Gheyle, L., Runge, F. E., Zimdahl‐Gelling, H., & Sand, M. S. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2569 · Cited by 30
Caveolin-1 regulation ofdisrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia
Kassan, A., Egawa, J., Zhang, Z., Almenar‐Queralt, A., Nguyen, Q. M., Lajevardi, Y., Kim, K., Posadas, E., Jeste, D. V., Roth, D. M., et al. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00481.2016 · Cited by 29
The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia
Pinacho, R., Vila, È., Prades, R., Tarragó, T., Castro, E., Ferrer, I., & Ramos, B. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.024 · Cited by 29
Role of PDE9 in Cognition
Dorner‐Ciossek, C., Kroker, K. S., & Rosenbrock, H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_9 · Cited by 29
Exploration of Allosteric Agonism Structure–Activity Relationships within an Acetylene Series of Metabotropic Glutamate Receptor 5 (mGlu5) Positive Allosteric Modulators (PAMs): Discovery of 5-((3-Fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254)
Turlington, M., Noetzel, M. J., Chun, A. C., Zhou, Y., Gogliotti, R. D., Nguyen, E. D., Gregory, K. J., Vinson, P. N., Rook, J. M., Gogi, K. K., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401028t · Cited by 28
Better pharmacotherapy for schizophrenia: What does the future hold?
Webber, M. A., & Marder, S. R. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0056-8 · Cited by 28
Sex Differences Distinguish Intracortical Glutamate Receptor-Mediated Regulation of Extracellular Dopamine Levels in the Prefrontal Cortex of Adult Rats
Locklear, M. N., Cohen, A. B., Jone, A., & Kritzer, M. F. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu222 · Cited by 28
N-methyl-D-aspartate receptor hypofunction as a potential contributor to the progression and manifestation of many neurological disorders
Dong, B., Yang, Y., Han, D., & Wang, Y. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1174738 · Cited by 30
Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia
Koola, M. M., Praharaj, S. K., & Pillai, A. (2019) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-019-00174-5 · Cited by 27
Neonatal ventral hippocampal lesions in male and female rats: Effects on water maze, locomotor activity, plus-maze and prefrontal cortical GABA and glutamate release in adulthood
Beninger, R. J., Tuerke, K. J., Forsyth, J. K., Giles, A. C., Xue, L., Boegman, R. J., & Jhamandas, K. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.044 · Cited by 30
The interactive effect of genetic polymorphisms of IL-10 and COMT on cognitive function in schizophrenia
Wang, J., Xu, H., Wang, D., Wei, G., Zhou, H., Wang, L., Zhou, Y., & Zhang, X. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.10.021 · Cited by 27
Bidirectional signaling of ErbB and Eph receptors at synapses
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2008) · Neuron Glia Biology · doi:10.1017/s1740925x09990287 · Cited by 27
Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy
Sailasuta, N., Ananworanich, J., Lerdlum, S., Sithinamsuwan, P., Fletcher, J. L. K., Tipsuk, S., Pothisri, M., Jadwattanakul, T., Jirajariyavej, S., Chalermchai, T., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000779 · Cited by 26
The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation
Fitzgerald, P. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.057 · Cited by 29
Chronobiology Revisited in Psychiatric Disorders: From a Translational Perspective
Kırlıoglu, S. S., & Balcıoğlu, Y. H. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0129 · Cited by 28
Inhibitory regulation of calcium transients in prefrontal dendritic spines is compromised by a nonsense Shank3 mutation
Ali, F., Shao, L.-X., Gerhard, D. M., Sweasy, K., Pothula, S., Pittenger, C., Duman, R. S., & Kwan, A. C. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0708-6 · Cited by 25
5-HT6 Receptor Ligands and their Antipsychotic Potential
Arnt, J., & Olsen, C. K. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-385902-0.00006-1 · Cited by 26
In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia
Bojarski, Ł., Debowska, K., & Wojda, U. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.020 · Cited by 25
Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice
Kutiyanawalla, A., Promsote, W., Terry, A. V., & Pillai, A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001180 · Cited by 27
Elevated plasma γ-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia
Cai, H., Zhu, R., Huan-de, L., Zhang, X., Hu, L., Yang, W. Y., & Ye, H.-S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.006 · Cited by 26
Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation
Tanaka, S. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-41 · Cited by 26
Modeling neuropathologies as disruption of normal sequence generation in working memory networks
Verduzco-Flores, S. O., Ermentrout, B., & Bodner, M. (2011) · Neural Networks · doi:10.1016/j.neunet.2011.09.007 · Cited by 25
Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition
Xiao, X., Dawson, N., MacIntyre, L., MORRIS, B. J., Pratt, J. A., Watson, D. G., & Higham, D. J. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-72 · Cited by 24
The Effects of Clonidine on Discrete-Trial Delayed Spatial Alternation in Two Rat Models of Memory Loss
Bardgett, M. E., Points, M., Ramsey-Faulkner, C., Topmiller, J., Roflow, J., McDaniel, T., Lamontagne, T., & Griffith, M. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301580 · Cited by 25
High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans
O’Neill, B. V., Croft, R. J., Leung, S., Oliver, C., Phan, K. L., & Nathan, P. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0870-4 · Cited by 25
Increased cortical nitric oxide release after phencyclidine administration
Pålsson, E., Finnerty, N. J., Fejgin, K., Klamer, D., Wass, C., Svensson, L., & Lowry, J. (2009) · Synapse · doi:10.1002/syn.20690 · Cited by 24
Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential
Flintoff, J. M., Kesby, J. P., Siskind, D. J., & Burne, T. H. J. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1951702 · Cited by 25
Ventrolateral prefrontal cortex and the effects of task demand context on facial affect appraisal in schizophrenia
Leitman, D. I., Wolf, D. H., Loughead, J., Valdez, J. N., Kohler, C. G., Brensinger, C. M., Elliott, M. A., Turetsky, B. I., Gur, R. E., & Gur, R. C. (2010) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsq018 · Cited by 28
Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia
Koychev, I., Barkus, E., Ettinger, U., Killcross, S., Roiser, J. P., Wilkinson, L., & Deakin, B. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111414450 · Cited by 24
Sex-specific attentional deficits in adult vitamin D deficient BALB/c mice
Groves, N. J., & Burne, T. H. J. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.01.033 · Cited by 24
Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions
Chang, C., Chen, Y.-W., Wang, T., & Lai, W. (2016) · Scientific Reports · doi:10.1038/srep33095 · Cited by 28
Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition.
Wenneberg, C., Nordentoft, M., Rostrup, E., Glenthøj, L., Bojesen, K., Fagerlund, B., Hjorthøj, C., Krakauer, K., Kristensen, T. D., Schwartz, C., et al. (2019) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.12.005 · Cited by 28
KangPiLao decoction modulates cognitive and emotional disorders in rats with central fatigue through the GABA/Glu pathway
Xu, Y., Lian, Y., Li, J., Zhang, Y., Liu, Y., Wang, X., Ma, J., & Li, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.939169 · Cited by 23
Afferent Drive of Medial Prefrontal Cortex by Hippocampus and Amygdala is Altered in MAM-Treated Rats: Evidence for Interneuron Dysfunction
Esmaeili, B., & Grace, A. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.64 · Cited by 22
Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release
Bortz, D. M., Mikkelsen, J. D., & Bruno, J. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.047 · Cited by 23
Glycine transporter-1 inhibitors: a patent review (2011–2016)
Cioffi, C. L. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1429408 · Cited by 23
How could N-Methyl-D-Aspartate Receptor Antagonists Lead to Excitation Instead of Inhibition?
Su, T., Lu, Y., Geng, Y., Lü, W., & Chen, Y. (2018) · Brain Science Advances · doi:10.26599/bsa.2018.2018.9050009 · Cited by 26
The mGluR2/3 Agonist LY379268 Blocks the Effects of GLT-1 Upregulation on Prepulse Inhibition of the Startle Reflex in Adult Rats
Bellesi, M., & Conti, F. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.225 · Cited by 22
α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia
Kucinski, A. J., Syposs, C., Wersinger, S. R., Bencherif, M., Stachowiak, M. K., & Stachowiak, E. K. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.005 · Cited by 22
Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls.
Yang, Z., Zhu, Y., Song, Z., Li, M., Zhang, J., Chen, T., Wang, Y., Xu, Y., Jiang, K., Li, Y., et al. (2015) · PubMed Central · doi:10.11919/j.issn.1002-0829.215130 · Cited by 22
The effect of distracting noise on the neuronal mechanisms of attention in schizophrenia
Tregellas, J. R., Smucny, J., Eichman, L. C., & Rojas, D. C. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.008 · Cited by 23
Biomarkers in Psychosis: An Approach to Early Identification and Individualized Treatment
Mirzakhanian, H., Singh, F., & Cadenhead, K. S. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.134 · Cited by 21
Gonadectomy but not biological sex affects burst‐firing in dopamine neurons of the ventral tegmental area and in prefrontal cortical neurons projecting to the ventral tegmentum in adult rats
Locklear, M. N., Michaelos, M., Collins, W. F., & Kritzer, M. F. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13380 · Cited by 21
Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia
Liu, Y., Lu, S., & Yao, J. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12528 · Cited by 22
Gene polymorphisms and response to transcranial direct current stimulation for auditory verbal hallucinations in schizophrenia
Chhabra, H., Shivakumar, V., Subbanna, M., Kalmady, S. V., Bose, A., Agarwal, S. M., Sreeraj, V. S., Dinakaran, D., Narayanaswamy, J. C., Debnath, M., et al. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.4 · Cited by 20
GABAergic mRNA expression is differentially expressed across the prelimbic and orbitofrontal cortices of rats sensitized to methamphetamine: Relevance to psychosis
Wearne, T. A., Parker, L. M., Franklin, J. L., Goodchild, A. K., & Cornish, J. L. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.038 · Cited by 21
Handbook of neurochemistry and molecular neurobiology, schizophrenia
Lajtha, Á., Javitt, D. C., & Kantrowitz, J. T. (2009) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · doi:10.1007/978-0-387-30410-6 · Cited by 21
Decline in age‐dependent, MK801‐induced injury coincides with developmental switch in parvalbumin expression: Somatosensory and motor cortex
Tomé, C. M. L., Miller, R., Bauer, C. T., Smith, C. M., Blackstone, K., Leigh, A., Busch, J., & Turner, C. P. (2008) · Developmental Psychobiology · doi:10.1002/dev.20325 · Cited by 21
Sertindole restores attentional performance and suppresses glutamate release induced by the NMDA receptor antagonist CPP
Carli, M., Calcagno, E., Mainini, E., Arnt, J., & Invernizzi, R. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2066-6 · Cited by 20
GABAergic dysfunction in postmortem dorsolateral prefrontal cortex: implications for cognitive deficits in schizophrenia and affective disorders
Hughes, H., Brady, L. J., & Schoonover, K. E. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1440834 · Cited by 20
Synaptic underpinnings of altered hippocampal function in glutaminase‐deficient mice during maturation
Gaisler‐Salomon, I., Wang, Y., Chuhma, N., Zhang, H., Golumbic, Y. N., Mihali, A., Arancio, O., Sibille, E. L., & Rayport, S. (2012) · Hippocampus · doi:10.1002/hipo.22014 · Cited by 20
N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia
Rogóż, Z., Kamińska, K., Lech, M. A., & Lorenc‐Koci, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042125 · Cited by 21
Spatiotemporal relationships between neuronal, metabolic, and hemodynamic signals in the awake and anesthetized mouse brain
Wang, X., Padawer-Curry, J. A., Bice, A. R., Kim, B., Rosenthal, Z. P., Lee, J., Goyal, M. S., Macauley, S. L., & Bauer, A. Q. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114723 · Cited by 23
Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study
Vingerhoets, C., Tse, D. H. Y., van Oudenaren, M. J. F., Hernaus, D., van Duin, E. D. A., Zinkstok, J., Ramaekers, J. G., Jansen, J. F. A., McAlonan, G. M., & van Amelsvoort, T. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120922977 · Cited by 19
Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex
Maćkowiak, M., Dudys, D., Chocyk, A., & Wędzony, K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.10.001 · Cited by 19
A Review of Glutamate Receptors II: Pathophysiology and Pathology
Rousseaux, C. G. (2008) · Journal of Toxicologic Pathology · doi:10.1293/tox.21.133 · Cited by 19
Optogenetic approaches for investigating neural pathways implicated in schizophrenia and related disorders
Cho, K. K. A., & Sohal, V. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu225 · Cited by 19
Animal models of neuropsychiatric
Hyman, S. E. (2010) · Cited by 18
Schizophrenia-associated dysbindin modulates axonal mitochondrial movement in cooperation with p150glued
Suh, B. K., Lee, S., Park, C., Suh, Y., Kim, S. J., Woo, Y. S., Nhung, T. T. M., Lee, S. B., Mun, D. J., Goo, B. S., et al. (2021) · Molecular Brain · doi:10.1186/s13041-020-00720-3 · Cited by 18
Developmental exposure to the organochlorine insecticide endosulfan alters expression of proteins associated with neurotransmission in the frontal cortex
Wilson, W. W., Onyenwe, W., Bradner, J. M., Nennig, S. E., & Caudle, W. M. (2014) · Synapse · doi:10.1002/syn.21764 · Cited by 18
Disruption of prefrontal cortical–hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride
Belujon, P., Patton, M. H., & Grace, A. A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571200106x · Cited by 18
Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague–Dawley Rats
Lech, M. A., Leśkiewicz, M., Kamińska, K., Rogóż, Z., & Lorenc‐Koci, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126171 · Cited by 20
Effects of (+)-bicuculline, a GABAa receptor antagonist, on auditory steady state response in free-moving rats
Yamazaki, M., Honda, S., Tamaki, K., Irie, M., & Mihara, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236363 · Cited by 17
Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity
Naujock, M., Speidel, A., Fischer, S. E., Kizner, V., Dorner‐Ciossek, C., & Gillardon, F. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0082 · Cited by 18
Connexin Hemichannel Mimetic Peptide Attenuates Cortical Interneuron Loss and Perineuronal Net Disruption Following Cerebral Ischemia in Near-Term Fetal Sheep
Yang, P., Davidson, J. O., Fowke, T. M., Galinsky, R., Wassink, G., Karunasinghe, R. N., Prasad, J. D., Ranasinghe, S., Green, C. R., Bennet, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186475 · Cited by 17
Contributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia
Krystal, J. H., & Moghaddam, B. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch21 · Cited by 17
Self-citation
Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine
Sultana, S., Li, H., Puché, A. C., Jones, O. D., Bryant, J., & Royal, W. (2010) · Journal of NeuroVirology · doi:10.3109/13550280903555712 · Cited by 16
Synaptic activity: An emerging player in schizophrenia
Sarkar, A., Marchetto, M. C., & Gage, F. H. (2015) · Brain Research · doi:10.1016/j.brainres.2015.12.028 · Cited by 16
Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats
Ahnaou, A., Biermans, R., & Drinkenburg, W. H. I. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147365 · Cited by 17
Effects of genetic variations in NRG1 on cognitive domains in patients with schizophrenia and healthy individuals
Cho, Y., Ryu, S., Huh, I., Cho, E. Y., Oh, H., Lee, Y. S., Lee, W. K., Park, T., Kwon, J. S., & Hong, K. S. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000087 · Cited by 16
Decline in age‐dependent, MK801‐induced injury coincides with developmental switch in parvalbumin expression: Cingulate and retrosplenial cortex
Tomé, C. M. L., Miller, R., Bauer, C. T., Nottingham, C. U., Smith, C. M., Blackstone, K., Brown, L. M., Bryan, R., Leigh, A., Brady, M. L., et al. (2007) · Developmental Psychobiology · doi:10.1002/dev.20246 · Cited by 16
Memantine normalizes brain activity in the inferior frontal gyrus: A controlled pilot fMRI study
Cerullo, M. A., Nasrallah, H. A., Eliassen, J. C., Adler, C. M., Nasrallah, A. T., & Strakowski, S. M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.07.034 · Cited by 16
Expression Profiles of Mitochondrial Genes in the Frontal Cortex and the Caudate Nucleus of Developing Humans and Mice Selectively Bred for High and Low Fear
Choi, K. H., Le, T., McGuire, J. L., Coyner, J. L., Higgs, B. W., Diglisic, S., Johnson, L. R., Benedek, D. M., & Ursano, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049183 · Cited by 15
Synthesis and Biological Evaluation ofN-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1
Cioffi, C. L., Liu, S., Wolf, M. A., Guzzo, P. R., Sadalapure, K., Parthasarathy, V., Loong, D. T. J., Maeng, J.-H., Carulli, E., Fang, X., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00914 · Cited by 15
Local N-Methyl-D-Aspartate Receptor Antagonism in the Prefrontal Cortex Attenuates Spatial Cognitive Deficits Induced by Gonadectomy in Adult Male Rats
Locklear, M., Bhamidipaty, S., & Kritzer, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.032 · Cited by 16
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia
Gomes, F. V., Edelson, J. R., Volk, D. W., & Grace, A. A. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.04.030 · Cited by 15
The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders
Palmisano, A., Pandit, S., Smeralda, C. L., Demchenko, I., Rossi, S., Battelli, L., Rivolta, D., Bhat, V., & Santarnecchi, E. (2024) · Life · doi:10.3390/life14050578 · Cited by 17
Ionotropic but not metabotropic glutamatergic receptors in the locus coeruleus modulate the hypercapnic ventilatory response in unanaesthetized rats
Taxini, C. L., Puga, C. C. I., Dias, M. B., Bícego, K. C., & Gargaglioni, L. H. (2013) · Acta Physiologica · doi:10.1111/apha.12082 · Cited by 14
Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study
Ji, B., Mei, W., Zhang, J. X., Jing, J., Wu, Q., Zhuo, Y., & Xiao, Z. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3600-7 · Cited by 14
Dehydroepiandrosterone and Pregnenolone Alterations in Schizophrenia
Ritsner, M. S., Gibel, A., Ratner, Y., & Weizman, A. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_14 · Cited by 14
The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex
Welty, N., & Shoblock, J. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1670-9 · Cited by 14
Abnormalities of the glutamine–glutamate–GABA cycle in the schizophrenia brain
Hashimoto, K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.008 · Cited by 14
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
Kumar, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010152 · Cited by 15
Increasing the Excitatory Drive Rescues Excitatory/Inhibitory Imbalance and Mismatch Negativity Deficit Caused by Parvalbumin Specific GluA1 Deletion
Chen-Engerer, H.-J., Jaeger, S., Bondarenko, R., Sprengel, R., Hengerer, B., Rosenbrock, H., Mack, V., & Schuelert, N. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.027 · Cited by 13

Authors: Lewis, D. A., & Moghaddam, B.
Affiliations: University of Pittsburgh (US)
ORCID: Lewis, David A.
Moghaddam, Bita
Venue: Archives of Neurology
Publisher: American Medical Association (AMA)
Published: 2006-10-01
Volume: 63
Issue: 10
Pages: 1372
ISSN: 0003-9942 (ISSN-L)
DOI: 10.1001/archneur.63.10.1372
OpenAlex: W2037549116
Cited by: 404
References: 41
Citations by year: 2026: 4 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 9 · 2021: 11 · 2020: 11 · 2019: 12 · 2018: 16 · 2017: 13 · 2016: 17 · 2015: 22 · 2014: 28 · 2013: 25 · 2012: 39
FWCI: 20.65
Type: journal article
Language: en
Open access: closed
Locations: Archives of Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression
National Institutes of Health (5r01mh048404-30, MH043784, MH045156)
National Institute of Mental Health (MH-045156, R01-MH048404, MH051234, R37MH048404, R01MH051234, P50MH045156, MH065026, R21MH065026, MH043784, MH048404)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: schizophrenia, cognitive impairment, working memory, dorsolateral prefrontal cortex, GABAergic inhibition, glutamatergic excitation, parvalbumin, NMDA receptor, neuronal synchronization, therapeutic target
MeSH terms: Animals, Cognition Disorders, gamma-Aminobutyric Acid, Humans, Neural Inhibition, Synaptic Transmission, Schizophrenia, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, Pyramidal Cells, Glutamic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cognitive Dysfunction in Schizophrenia: Convergence of γ-Aminobutyric Acid and Glutamate Alterations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks